Pretransplant albumin, absolute count of CD4+ cells, elevated C-reactive protein, and history of sepsis predict early mortality with high performance in both training and validation sets (training set: AUC 0.83, sensitivity 0.77, and specificity 0.77; validation set: AUC 0.74, sensitivity 0.54, and specificity 0.82). This evidence concerns the gene ALB and Sepsis.